KCNJ5 Somatic Mutations Are Associated With Better Long-term Outcomes in Patients With Unilateral Primary Aldosteronism
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf007 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Chieh-Kai Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu City 300195, Taiwan. Hauptthemen laut MEDLINE: G Protein-Coupled Inwardly-Rectifying Potassium Channels, Hyperaldosteronism, Adrenalectomy, Mutation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Ministry of Science and Technology (MOST), National Science and Technology Council (NSTC), National Health Research Institutes.
Abstract (Originalsprache)
Context
The association between KCNJ5 somatic mutations and long-term outcomes in patients with operated unilateral primary aldosteronism (uPA) is unclear.
Objective
To evaluate associations among KCNJ5 somatic mutations, clinical characteristics, incident long-term cardiovascular events, and all-cause mortality in patients with uPA after adrenalectomy in a large longitudinal population study.
Methods
We enrolled patients with uPA from the Taiwan Primary Aldosteronism Investigation database who had undergone adrenalectomy between 2013 and 2017 and followed them until 2020. The outcomes were achieving complete clinical success at 1 year after adrenalectomy, long-term major adverse cardiac and cerebrovascular events (MACCEs), and mortality.
Results
Of the 358 enrolled patients (46.7% men; mean age, 51.3 years), 188 (52.5%) harbored KCNJ5 somatic mutations. The baseline characteristics of younger age (odds ratio [OR] = 2.44; P = .001), lower body mass index (OR = 2.04; P = .005), lower potassium (OR = 6.55; P < .001), and larger tumor size (OR = 2.05; P = .023) were potential predictors of KCNJ5 somatic mutations. The patients with uPA who were operated on and harboring KCNJ5 somatic mutations were associated with a higher likelihood of complete clinical success at 1 year after adrenalectomy (OR = 1.98; P = .016). KCNJ5 somatic mutation carriers (hazard ratio [HR] = 0.46; P = .044), those with a shorter duration of hypertension (HR = 1.05; P = .008), and those who achieved complete clinical success (HR = 0.49; P = .036) had a lower risk of MACCEs and mortality.
Conclusion
Patients with uPA harboring KCNJ5 somatic mutations had a lower risk of long-term MACCEs and mortality following adrenalectomy. These patients were more likely to achieve complete clinical success, which contributed to improved outcomes. However, the benefits were influenced by factors such as baseline potassium levels, hypertension duration, BMI, eGFR, and residual hypertension, highlighting the interplay of genetic and clinical factors in determining prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu City 300195, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei City 100225, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei City 100225, Taiwan.
- TAIPAI, Taiwan Primary Aldosteronism Investigation Study Group, Taipei City 100225, Taiwan.
- National Taiwan University Hospital-Primary Aldosteronism Center (NTUH-PAC), Taipei City 100225, Taiwan.
- Department of Medical Imaging, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City 100225, Taiwan.
ORCID-Profile: Chieh-Kai Chan, Yen-Hung Lin, Chin-Chen Chang, Vin-Cent Wu, Jeff S Chueh
Förderung
- Ministry of Science and Technology (MOST)
- National Science and Technology Council (NSTC)
- National Health Research Institutes
- National Taiwan University Hospital
- Mrs. Hsiu-Chin Lee Kidney Research Fund
Zitieren
APA
Chan, C. K., Yang, W. S., Lin, Y. H., Chang, C. C., Wu, V. C., & Chueh, J. S. (2025). KCNJ5 Somatic Mutations Are Associated With Better Long-term Outcomes in Patients With Unilateral Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf007
Vancouver
Chan CK, Yang WS, Lin YH, Chang CC, Wu VC, Chueh JS. KCNJ5 Somatic Mutations Are Associated With Better Long-term Outcomes in Patients With Unilateral Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf007
BibTeX
@article{Chan2025,
author = {Chan, Chieh-Kai and Yang, Wei-Shiung and Lin, Yen-Hung and Chang, Chin-Chen and Wu, Vin-Cent and Chueh, Jeff S},
title = {KCNJ5 Somatic Mutations Are Associated With Better Long-term Outcomes in Patients With Unilateral Primary Aldosteronism},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf007}
}
EUVIMED